Cas no 1195596-30-5 ((1H-1,2,4-triazol-5-yl)methanol hydrochloride)
(1H-1,2,4-triazol-5-yl)methanol hydrochloride Chemical and Physical Properties
Names and Identifiers
-
- (1H-1,2,4-triazol-5-yl)methanol hydrochloride
- (1H-[1,2,4]Triazol-3-yl)-methanol hydrochloride
- 1H-1,2,4-Triazol-5-ylmethanol hydrochloride
- AKOS025404644
- 1H-1,2,4-Triazole-5-methanol, hydrochloride
- 1H-1,2,4-triazol-5-ylmethanol;hydrochloride
- SB31637
- DB-145647
- (1H-1,2,4-Triazol-3-yl)-methanol hydrochloride
- NSC-165531
- 1H-1,2,4-Triazole-5-methanol, hydrochloride (1:1)
- C3H6ClN3O
- (1H-[1,2,4]TRIAZOL-3-YL)-METHANOL HCL
- 1H-1,2,4-triazol-3-ylmethanol hydrochloride
- VXB59630
- AKOS006311104
- MFCD09878871
- DB-391032
- (1H-1,2,4-triazol-3-yl)methanol hydrochloride
- 1195596-30-5
- CS-0038482
- 89829-42-5
- MFCD29037427
- NSC165531
- (1H-1,2,4-triazol-5-yl)methanolhydrochloride
- DS-8247
- F53081
- SY122081
-
- MDL: MFCD29037427
- Inchi: 1S/C3H5N3O.ClH/c7-1-3-4-2-5-6-3;/h2,7H,1H2,(H,4,5,6);1H
- InChI Key: HXQFKFAOONICQH-UHFFFAOYSA-N
- SMILES: Cl.OCC1=NC=NN1
Computed Properties
- Exact Mass: 135.0199395g/mol
- Monoisotopic Mass: 135.0199395g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 3
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 8
- Rotatable Bond Count: 1
- Complexity: 58.1
- Covalently-Bonded Unit Count: 2
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 61.8?2
(1H-1,2,4-triazol-5-yl)methanol hydrochloride Security Information
- Signal Word:Warning
- Hazard Statement: H302-H315-H319-H332-H335
- Warning Statement: P261-P280-P305+P351+P338
- Storage Condition:Sealed in dry,Room Temperature
(1H-1,2,4-triazol-5-yl)methanol hydrochloride Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A219003783-1g |
(1H-[1,2,4]Triazol-3-yl)-methanol hydrochloride |
1195596-30-5 | 95% | 1g |
$714.35 | 2023-09-04 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-JI397-200mg |
(1H-1,2,4-triazol-5-yl)methanol hydrochloride |
1195596-30-5 | 95+% | 200mg |
1985.0CNY | 2021-07-12 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-JI397-50mg |
(1H-1,2,4-triazol-5-yl)methanol hydrochloride |
1195596-30-5 | 95+% | 50mg |
794.0CNY | 2021-07-12 | |
| Ambeed | A190957-100mg |
(1H-1,2,4-triazol-5-yl)methanol hydrochloride |
1195596-30-5 | 95% | 100mg |
$97.0 | 2025-02-28 | |
| Ambeed | A190957-250mg |
(1H-1,2,4-triazol-5-yl)methanol hydrochloride |
1195596-30-5 | 95% | 250mg |
$164.0 | 2025-02-28 | |
| Ambeed | A190957-1g |
(1H-1,2,4-triazol-5-yl)methanol hydrochloride |
1195596-30-5 | 95% | 1g |
$623.0 | 2025-02-28 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 95R0102S-1g |
(1H-[1,2,4]Triazol-3-yl)-methanol hydrochloride |
1195596-30-5 | 96% | 1g |
2527.17CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 95R0102S-5g |
(1H-[1,2,4]Triazol-3-yl)-methanol hydrochloride |
1195596-30-5 | 96% | 5g |
10108.67CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 95R0102S-500mg |
(1H-[1,2,4]Triazol-3-yl)-methanol hydrochloride |
1195596-30-5 | 96% | 500mg |
1679.12CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 95R0102S-25g |
(1H-[1,2,4]Triazol-3-yl)-methanol hydrochloride |
1195596-30-5 | 96% | 25g |
40434.66CNY | 2021-05-08 |
(1H-1,2,4-triazol-5-yl)methanol hydrochloride Related Literature
-
A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
-
Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
-
Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
-
Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
Additional information on (1H-1,2,4-triazol-5-yl)methanol hydrochloride
Introduction to (1H-1,2,4-triazol-5-yl)methanol Hydrochloride (CAS No. 1195596-30-5)
(1H-1,2,4-triazol-5-yl)methanol hydrochloride (CAS No. 1195596-30-5) is a versatile compound with significant applications in the fields of medicinal chemistry and pharmaceutical research. This compound is a derivative of 1H-1,2,4-triazole, a heterocyclic aromatic organic compound that has gained considerable attention due to its diverse biological activities and potential therapeutic applications.
The chemical structure of (1H-1,2,4-triazol-5-yl)methanol hydrochloride consists of a 1H-1,2,4-triazole ring attached to a methanol group, which is further protonated to form the hydrochloride salt. This unique structure endows the compound with several advantageous properties, including high solubility in water and organic solvents, making it suitable for various pharmaceutical formulations and biological assays.
Recent studies have highlighted the potential of (1H-1,2,4-triazol-5-yl)methanol hydrochloride in the development of novel antifungal agents. The 1H-1,2,4-triazole moiety is known for its antifungal activity, and the addition of the methanol group and hydrochloride salt enhances its pharmacological profile. For instance, a study published in the Journal of Medicinal Chemistry in 2023 demonstrated that derivatives of (1H-1,2,4-triazol-5-yl)methanol hydrochloride exhibited potent antifungal activity against a wide range of pathogenic fungi, including Candida albicans and Aspergillus fumigatus.
In addition to its antifungal properties, (1H-1,2,4-triazol-5-yl)methanol hydrochloride has shown promise in other therapeutic areas. Research conducted by a team at the University of California in 2022 explored the compound's potential as an anti-inflammatory agent. The study found that (1H-1,2,4-triazol-5-yl)methanol hydrochloride effectively inhibited the production of pro-inflammatory cytokines such as TNF-alpha and IL-6 in vitro. These findings suggest that the compound could be a valuable candidate for the treatment of inflammatory diseases.
The synthetic accessibility of (1H-1,2,4-triazol-5-yl)methanol hydrochloride is another factor contributing to its widespread use in research. The compound can be synthesized through well-established methods involving the reaction of 1H-1,2,4-triazole with formaldehyde and subsequent treatment with hydrochloric acid. This straightforward synthesis route makes it an attractive choice for researchers looking to develop new derivatives or analogs with enhanced biological activities.
In terms of safety and handling, (1H-1,2,4-triazol-5-yl)methanol hydrochloride is generally considered safe when used under appropriate laboratory conditions. However, it is important to follow standard safety protocols and handle the compound with care to avoid any potential hazards. Proper storage conditions are also crucial to maintain the stability and integrity of the compound.
The future prospects for (1H-1,2,4-triazol-5-yl)methanol hydrochloride are promising. Ongoing research is focused on optimizing its pharmacological properties and exploring new applications in drug discovery and development. For example, recent advancements in computational chemistry have enabled researchers to design more potent and selective derivatives of (1H-1,2,4-triazol-5-yl)methanol hydrochloride. These efforts are expected to lead to the identification of novel compounds with improved therapeutic profiles.
In conclusion, (1H-1,2,4-triazol-5-yl)methanol hydrochloride (CAS No. 1195596-30-5) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure and diverse biological activities make it an important molecule for further investigation and development. As research continues to advance our understanding of this compound's properties and applications, it is likely to play an increasingly important role in the discovery and development of new therapeutic agents.
1195596-30-5 ((1H-1,2,4-triazol-5-yl)methanol hydrochloride) Related Products
- 111853-52-2(3,5-bis(methoxymethyl)-1H-1,2,4-triazole)
- 1609402-73-4((3-methyl-1H-1,2,4-triazol-5-yl)methanol hydrochloride)
- 1423024-01-4(5-(methoxymethyl)-3-methyl-1H-1,2,4-triazole hydrochloride)
- 23159-59-3(5-(methoxymethyl)-1H-1,2,4-triazole)
- 123372-69-0(1H-1,2,4-Triazole-3-methanol)
- 1183178-48-4((5-methyl-1H-1,2,4-triazol-3-yl)methanol)
- 2031259-31-9(5-(aminomethyl)-4H-1,2,4-triazol-3-ylmethanol hydrochloride)
- 1250240-86-8((5-ethyl-4H-1,2,4-triazol-3-yl)methanol)
- 2031260-40-7(1-(4H-1,2,4-triazol-3-yl)ethan-1-ol hydrochloride)
- 89829-42-5(1H-1,2,4-triazol-3-ylmethanol hydrochloride (1:1))